• Ann Tucker

ONDCP: Elimination of X-Waiver Requirement Announced Prematurely

Office of National Drug Control Policy: "On January 14, 2021, HHS announced forthcoming Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder. Unfortunately, the announcement was made prematurely. Therefore, the Guidelines previously announced cannot be issued at this time. However, HHS and ONDCP are committed to working with interagency partners to examine ways to increase access to buprenorphine, reduce overdose rates and save lives."

11 views0 comments

Recent Posts

See All

SAMHSA (11/10) –– The Substance Abuse and Mental Health Services Administration is pleased to announce the release of the agency’s Interim Strategic Plan (ISP), which presents a new mission and vision

The White House budget office is reviewing a draft SAMHSA rule that would make permanent the COVID-19 methadone take-home waiver and define which patients with OUD are considered “stable” enough to re